Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 1621 AL 1635

Mitochondrial Dynamics and SLC25 Transporters in Neurodegeneration: From Mechanisms to Therapeutic Opportunities

Morciano G, Gorgoglione R, Porcelli V, Ahmed A, Scarcia P, Vozza A, Lasorsa FM, Fiermonte G, Palmieri L.

Biomolecules. 2026 Jun 9;16(6):842. doi: 10.3390/biom16060842.

Spiritual Care Needs and Challenges Among Caregivers and Families of People with Neurodegenerative Diseases in Palliative and End-of-Life Care: A Scoping Review

De Luca E, Saba A, Bertarini L, Brusini A, Artioli G, Dellafiore F.

Brain Sci. 2026 Jun 4;16(6):611. doi: 10.3390/brainsci16060611.

The Dual Role of Glial Extracellular Vesicles in Neurodegeneration: Insights from iPSC-Based Models

Scrivo A, Bernardino L, Consiglio A.

Int J Mol Sci. 2026 Jun 8;27(12):5182. doi: 10.3390/ijms27125182.

Astragalus and Cordyceps Derivatives in the Treatment of Aging-Related Chronic Diseases and Neurodegenerative Disorders

Kanubaddi KR, Yaung CL, Harn HJ, Chiou TW, Hsu SX, Wijaya I, Lin SZ, Wuli W.

Int J Mol Sci. 2026 Jun 10;27(12):5273. doi: 10.3390/ijms27125273.

β-Amyloid (Aβ) and Human Cathelicidin LL-37: Two Sides of the Same Coin?

Asti AL.

Int J Mol Sci. 2026 Jun 17;27(12):5460. doi: 10.3390/ijms27125460.

Lipid Metabolism Reprogramming in the Aging Brain: Glial-Mediated Pathogenic Mechanisms and Translational Strategies in Neurodegeneration

Shao W, Wang K, Liu Y, Zhang H, Sun Z, Zhou R.

Int J Mol Sci. 2026 Jun 20;27(12):5580. doi: 10.3390/ijms27125580.

Dysregulation of the Extracellular Matrix in the Synaptic Pathology of Parkinson's Disease: Molecular Mechanisms and Novel Therapeutic Approaches

Rubio C, Pérez-Rubio R, Pérez-Villavicencio J, Serrano-García N, Lee Á, Granados-Rojas L, Tena-Suck M, Rubio-Osornio M.

Life (Basel). 2026 Jun 15;16(6):1007. doi: 10.3390/life16061007.

A Sensorimotor Framework for the Neurorehabilitation of Oculomotor Dysfunction in Parkinson's Disease

Yap TP.

J Clin Med. 2026 Jun 15;15(12):4639. doi: 10.3390/jcm15124639.

"Brain-First" vs. "Body-First" PD: Definitions and Implications in Everyday Clinical Practice: A Systematic Review

Pilateris I, Bostanjopoulou S.

Medicina (Kaunas). 2026 Jun 8;62(6):1116. doi: 10.3390/medicina62061116.

The Integrative Role of Berberine in Gut Microbiota Modulation and Cardiometabolic Outcomes: A Systematic Review of Randomised Clinical Trials

Candrea AR, Gavrilaș LI, Frumuzachi O, Mocan A, Babotă M, Crișan G.

Nutrients. 2026 Jun 9;18(12):1858. doi: 10.3390/nu18121858.

Targeting the Human Gut Microbiota-Between Conventional Therapy and Precision Genetic Engineering

Ciurea NA, Mahdi L, Graziani A, Di Ciaula A, Portincasa P, Khalil M.

Nutrients. 2026 Jun 17;18(12):1958. doi: 10.3390/nu18121958.

Research Progress on Novel Lead Compounds for Central Nervous System Diseases

Qiao Y, Chen J, Zhou Y, Shi W.

Pharmaceuticals (Basel). 2026 Jun 11;19(6):922. doi: 10.3390/ph19060922.

Transfer and Reinforcement Learning as Support Paradigms for Human Activity Recognition in Indoor Environments: A Comprehensive Analysis of Trends, Impact and Future Directions

Ariza-Colpas PP, Piñeres-Melo MA, Oviedo-Carrascal AI, Díaz Jiménez D.

Sensors (Basel). 2026 Jun 12;26(12):3751. doi: 10.3390/s26123751.

Advancing MSC-EV Therapies: Harnessing Preconditioning and Mito-EVs to Tackle Neuroinflammation and Neurodegeneration

Costanzi E, Fontana L, Giroldo F, Coco S.

Pharmaceutics. 2026 Jun 12;18(6):730. doi: 10.3390/pharmaceutics18060730.

α-Synuclein-Targeted Immunotherapies in Parkinson's Disease: In Silico, In Vitro and Clinical Perspectives

Santos TB, Machado TOX, Rodrigues PHS, Correa WS, Kodel HAC, Santos KS, Gomes MZ.

Molecules. 2026 Jun 10;31(12):2036. doi: 10.3390/molecules31122036.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias